Immunohistochemical Evaluation of Idiopathic Epiretinal Membranes and In Vitro Studies on the Effect of TGF-beta on Müller Cells by Bu, Shao-Chong et al.
  
 University of Groningen
Immunohistochemical Evaluation of Idiopathic Epiretinal Membranes and In Vitro Studies on
the Effect of TGF-beta on Müller Cells
Bu, Shao-Chong; Kuijer, Roel; van der Worp, Roelofje J.; Postma, Gina; Renardel De
Lavalette, Victor W.  ; Li, Xiao-Rong; Hooymans, Johanna M. M.; Los, Leonoor I.
Published in:
Investigative ophthalmology & visual science
DOI:
10.1167/iovs.14-15971
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2015
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Bu, S-C., Kuijer, R., van der Worp, R. J., Postma, G., Renardel De Lavalette, V. W., Li, X-R., ... Los, L. I.
(2015). Immunohistochemical Evaluation of Idiopathic Epiretinal Membranes and In Vitro Studies on the
Effect of TGF-beta on Müller Cells. Investigative ophthalmology & visual science, 56(11), 6506-6514.
https://doi.org/10.1167/iovs.14-15971
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Retinal Cell Biology
Immunohistochemical Evaluation of Idiopathic Epiretinal
Membranes and In Vitro Studies on the Effect of TGF-b on
Mu¨ller Cells
Shao-Chong Bu,1–3 Roel Kuijer,2,4 Roelofje J. van der Worp,1,2 Gina Postma,1
Victor W. Renardel de Lavalette,1 Xiao-Rong Li,3 Johanna M. M. Hooymans,1,2
and Leonoor I. Los1,2
1Department of Ophthalmology (BB61), University of Groningen, University Medical Center Groningen, RB Groningen, The
Netherlands
2W.J. Kolff Institute, Graduate School of Medical Sciences, University of Groningen, Groningen, The Netherlands
3Tianjin Medical University Eye Centre, Nan Kai District, Tianjin, China
4Department of Biomedical Engineering (FB40), University of Groningen, University Medical Center Groningen, AV Groningen, The
Netherlands
Correspondence: Leonoor I. Los,
University Medical Center Gronin-
gen, Department of Ophthalmology,
BB 61, PO Box 30.001, 9700 RB,
Groningen, The Netherlands;
l.i.los@umcg.nl.
Submitted: October 31, 2014
Accepted: July 27, 2015
Citation: Bu S-C, Kuijer R, van der
Worp RJ, et al. Immunohistochemical
evaluation of idiopathic epiretinal
membranes and in vitro studies on the
effect of TGF-b on Mu¨ller cells. Invest
Ophthalmol Vis Sci. 2015;56:6506–
6514. DOI:10.1167/iovs.14-15971
PURPOSE. The purpose of this study was to investigate the presence of type VI collagen and
glial cells in idiopathic epiretinal membrane (iERM) and the role of TGF-b in the expression of
collagens and a-smooth muscle actin (a-SMA) in retinal Mu¨ller cells.
METHODS. Idiopathic ERM samples from vitrectomy were analyzed for glial acidic fibrillary
protein (GFAP), cellular retinaldehyde-binding protein (CRALBP), a-SMA, and type VI collagen
using flat-mount immunohistochemistry. To study intracellular collagen expression in relation
to cellular phenotype, spontaneously immortalized human Mu¨ller cells (MIO-M1) were
treated with TGF-b1 for 48 hours, and the expression of a-SMA and intracellular type I, II, IV,
and VI collagens was studied by using immunocytology. Findings in Mu¨ller cells were
compared with those in fetal lung fibroblasts and newborn skin fibroblasts.
RESULTS. A colocalization of GFAP/CRALBP and GFAP/a-SMA was found in iERM, indicating a
dynamic process of activation of retinal Mu¨ller cells in vivo. Transforming growth factor-b1
induced up-regulation of a-SMA stress fibers in retinal Mu¨ller cells and both types of
fibroblasts in vitro. The intracellular staining intensity of type I, II, and VI collagens was
decreased in retinal Mu¨ller cells containing a-SMA stress fibers, whereas the intracellular
staining intensity of type I and VI collagens in both types of fibroblasts was not affected.
CONCLUSIONS. Type VI collagen and activated retinal Mu¨ller cells are present in iERM.
Transforming growth factor-b1 induces an up-regulation of a-SMA stress fibers in retinal
Mu¨ller cells and fibroblasts and appears to have a cell-specific effect on intracellular collagen
expression.
Keywords: retinal Mu¨ller cells, collagen, TGF-b, idiopathic epiretinal membranes
Macular distortion induced by epiretinal membrane (ERM)contraction is the major cause of visual disturbance in
idiopathic ERM (iERM)-associated retinopathy. During the
disease process, a cell matrix–mediated contraction of the
ERM causes a significant macular dysfunction, which may result
in symptoms such as metamorphopsia, reduction in visual
acuity, and, on occasion, central unilateral diplopia.1,2 Despite
the advancement of vitreo-retinal surgery, an iERM can result in
a certain level of irreversible visual disturbance even after an
uneventful iERM removal surgery, due to the fact that the prior
membrane contraction has resulted in permanent functional
damage to the retina.3,4 Some previous research focused on the
pathogenesis of iERM with the intention to develop novel
noninvasive treatment strategies to prevent ERM formation and
contraction.5
An iERM is a fibrocellular membrane containing two major
components: extracellular matrix (ECM) proteins and epi-
retinal cells of retinal and extraretinal origin. The presence of
type I, II, III, IV, V, and VI collagens has been reported in
iERMs.6,7 They form the structural framework that facilitates
the adhesion, migration, and proliferation of epiretinal cells.7–9
Among the various collagens in an iERM, type VI collagen is of
particular interest because of its regulatory role in the
proliferation, migration, and transdifferentiation of fibroblasts
in many fibrotic diseases.10,11 Several reports showed that the
up-regulation of type VI collagen was concomitant with the up-
regulation of type I collagen in fibroblasts during skin and lung
fibrosis.12,13
The development of an iERM is a fibrotic process in which
myofibroblasts are responsible for the excessive production of
collagenous extracellular matrix and for tissue contraction.14
Myofibroblasts have very heterogeneous origins in different
organs.15 In fibro-contractive vitreoretinal diseases, retinal
Mu¨ller cells, hyalocytes, and retinal pigment epithelial cells
may all differentiate into a myofibroblast-like phenotype and
may thus contribute to collagen deposition and membrane
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contraction.16–18 Of importance in iERM development are
recent studies showing that retinal Mu¨ller cells in the presence
of certain profibrotic cytokines can transdifferentiate into a
myofibroblast-like phenotype and start to produce a-smooth
muscle actin (a-SMA) and induce tissue contraction.19,20
The TGF-b family of signaling proteins is a group of potent
fibrogenic cytokines that play a crucial role in normal tissue
repair and development of fibrosis by mediating inflammatory
response, up-regulating extracellular matrix production, de-
creasing protease synthesis, and inducing myofibroblast
differentiation.21 Two of the isoforms of TGF-b, namely TGF-
b1 and b2, may be involved in the pathogenesis of iERM based
on their up-regulation in the vitreous humor and in epiretinal
membranes.22–24 Several reports indicate that TGF-b is
involved in the formation of epiretinal membrane by regulating
the proliferation, migration, and transdifferentiation of retinal
Mu¨ller cells.19,25 However, the role of transdifferentiated retinal
Mu¨ller cells in collagen synthesis during iERM formation has
not yet been clarified. In a previous study, we showed that
retinal Mu¨ller cells can produce a series of collagens that could
be involved in the dynamic turnover of the vitreo-retinal matrix
in physiologic and pathologic situations.26 Therefore, we
hypothesized that type VI collagen is one of the ECM proteins
in the iERM and that TGF-b stimulates the retinal Mu¨ller cell to
transdifferentiate into a myofibroblast-like phenotype that is
responsible for the up-regulation of type VI collagen. This
hypothesis is based on previous studies in which a TGF-b1–
induced up-regulation of the expression of type I and VI
collagens in fibroblasts was seen.27,28
The present study evaluates flat-mounted surgical speci-
mens of iERM for evidence of the presence of type VI collagen
and of transdifferentiation of retinal Mu¨ller cells, that is, cells
expressing both a-SMA (myofibroblast marker) and glial acidic
fibrillary protein (GFAP; marker of Mu¨ller cells and Mu¨ller cell
activation). In addition, we compared the staining patterns of
collagens in cultured TGF-b1–treated retinal Mu¨ller cells with
those in cultured TGF-b1–treated newborn skin and fetal lung
fibroblasts.
MATERIALS AND METHODS
Inner Limiting Membrane/ERM Flat Mount and
Immunofluorescence
General Procedures. Twenty-two patients (16 females and
6 males) who were referred to the Ophthalmology Department
of the University Medical Center Groningen for iERM surgery
were involved in the study between June 2010 and June 2012.
The mean age of the patients was 69.6 years (range, 53–84
years). Prior to their scheduled surgery, a complete ophthalmic
examination was performed, and written informed consent
was obtained. This study was conducted in accord with the
Declaration of Helsinki and was approved by the Institutional
Review Board of the University Medical Center Groningen.
The surgical technique involved a standard three-ports
trans pars plana vitrectomy, creation of a posterior vitreous
detachment if necessary, and inner limiting membrane (ILM)/
ERM peeling with the aid of Membrane blue (DORC, Zuidland,
The Netherlands). Peeling was performed with an end-gripping
forceps, intending to remove the ERM and ILM over an area of
more than 1.5 disc diameters surrounding the macula. All
vitrectomy procedures were performed by two experienced
vitreo-retinal surgeons (coauthors VWRL and GP). The ERM/
ILM samples were immediately processed for flat-mount
immunohistochemical analysis.
Flat-Mount and Immunohistochemistry of ILM/ERM
Specimens. The procedures for flat-mount and immunohis-
tochemistry of ILM/ERM specimens were described previ-
ously.29 Briefly, the ILM/ERM specimens were placed on a
silicone elastomer (SYLGARD 184; Dow Corning Corpora-
tion, Midland, MI, USA)–coated petri dish in 200 lL 1% PBS
containing 2% Tween 20 (PBST; Bio-Rad, Hercules, CA, USA).
Using a stereomicroscope, the specimens were flattened with
fine glass sticks and pinned to the dish with stainless steel
pins (Austerlitz Insect Pins; Fine Science Tools, Inc., Foster
City, CA, USA). Subsequently, the flattened specimens were
fixed in 2% paraformaldehyde for 30 minutes, washed three
times in PBST for 15 minutes, blocked with PBST containing
5% BSA (Sigma-Aldrich Corp., St. Louis, MO, USA) for 60
minutes, and incubated overnight at 48C in a mixture of two
primary antibodies (both diluted to 1:200). Primary antibod-
ies used included rabbit (polyclonal; Abcam, Cambridge, UK)
or mouse (monoclonal; Sigma-Aldrich Corp.) anti-GFAP (glial
cell marker, may be present in quiescent Mu¨ller cells, but is
up-regulated in case of Mu¨ller cell activation); rabbit anti-
cellular retinaldehyde-binding protein antibody (CRALBP;
Mu¨ller cell marker, UW55, a kind gift from JC Saari,
University of Washington, Seattle, WA, USA), mouse anti–a-
SMA (monoclonal; Sigma-Aldrich Corp.), and rabbit anti–type
VI collagen antibody (polyclonal; Abcam). The combinations
of the primary antibodies used in the study included the
following: CRALBP/GFAP (2 cases), CRALBP/a-SMA (2 cases),
GFAP/a-SMA (4 cases), type VI collagen/GFAP (10 cases), and
type VI collagen/a-SMA (2 cases). Two samples were used as
negative controls for the primary antibodies.
The samples were rinsed three times with PBST for 15
minutes and incubated for 4 hours at 48C with two fluorescent-
labeled secondary antibodies (diluted 1:200) combined with
4060-diamino-2-phenylindole (DAPI; diluted 1:200 for visualiz-
ing nuclei; Sigma-Aldrich Corp.). Secondary antibodies used
include donkey anti-rabbit antibody conjugated with RedX,
donkey anti-goat antibody with FITC, and donkey anti-mouse
with FITC (Jackson ImmunoResearch Laboratories, Inc., West
Grove, PA, USA).
After incubation, the specimens were washed three times in
PBST for 15 minutes and removed from the petri dish. Using a
stereomicroscope, the specimens were flattened on a glass
slide in a drop of antifadent (AF1; Citifluor, Ltd., London, UK)
and sealed with a cover slip. Negative control samples
underwent the entire procedure, except for the application
of the primary antibodies.
To confirm the specificity of the anti-collagen I, II, IV, and VI
antibodies, labeling procedures were done on samples from a
paraffin-embedded human donor eye containing vitreous body,
retina, choroid, and sclera. Control samples consisted of
sections that underwent the entire procedure, without
application of the primary antibody and sections that were
incubated with an isotype control goat or rabbit IgG (1:150;
Southern Biotechnology Associates [SBA], Birmingham, AL,
USA) and underwent the further labeling procedure.
Effect of TGF-b1 on Intracellular Collagen
Expression in a-SMA–Positive Cells
Cell Culture. The spontaneously immortalized human
Mu¨ller cell line MIO-MI (a kind gift from GA Limb, UCL
Institute of Ophthalmology, London, UK) has been confirmed
to contain important characteristics of human Mu¨ller cells,
such as the expression of CRALBP and only limited expression
of GFAP.30 Dulbecco’s modified Eagle’s medium with high
glucose containing L-glutamax I (Life Technologies, Inc.,
Rockville, MD, USA) supplemented with 1% penicillin/strepto-
mycin and 10% fetal bovine serum (FBS; Life Technologies,
Inc.) was the stock medium. The stock culture of MIO-MI
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(passage between 61 and 70) was maintained in stock medium
at 378C with 5% CO2 for the experiments.
Fetal lung fibroblasts were incubated in DMEM with high
glucose containing L-glutamax I (Life Technologies, Inc.)
supplemented with gentamicin/glutamin and 10% FBS at
378C with 5% CO2.
Newborn skin fibroblasts (CCD-1112Sk; American Type
Culture Collection, Manassas, VA, USA) were incubated in
stock medium at 378C with 5% CO2.
Effect of TGF-b1 on Retinal Mu¨ller Cells. The cells were
seeded on glass cover slips in six-well plates in their stock
culture medium with the addition of 0.2 mM ascorbic acid.
After 24 hours of incubation, 10 ng/mL recombinant TGF-b1
was added to the medium for another 48 hours of culture.
Subsequently, the cells were processed for immuno-double
labeling to identify the colocalization of a-SMA and collagens
including type I, II, IV, and VI collagens. The primary and
secondary antibodies used are listed in Table 1. Briefly, the
cells were washed three times in PBS and fixed in 1:1
acetone/methanol at208C for 10 minutes. Then, the fixative
was discarded, and the slides were air-dried and stored at
208C until further use. After blocking with 5% BSA (Sigma-
Aldrich Corp.) in PBS, the cells were incubated in a mixture
of primary antibodies including a mouse anti–a-SMA antibody
and one of the anti-collagen antibodies for 2 hours at room
temperature. Afterward, they were rinsed in PBS three times
for 5 minutes and incubated in a combination of two
secondary antibodies according to the host of the primary
antibodies and DAPI as described previously for 2 hours in a
dark room. After washing in PBS, a drop of antifadent (AF1;
Citifluor, Ltd., London, UK) was applied to each cover slip,
and the cover slips were placed on a slide and sealed. For
negative controls, the samples underwent the entire proce-
dure, and the primary antibody was omitted. Western blot
analysis was used to check the specificity of the antibodies
and to evaluate intracellular protein expression (GFAP, a-
SMA, and type VI collagen). For this, MIO-M1 cells were
harvested in denaturation buffer (10 mM Tris-HCl, pH 7,
containing 1 mM EDTA, 2.5% SDS, 5% 2-mercaptoethanol,
and 10% glycerol), and proteins were analyzed by SDS-PAGE
according the method of Laemmli using a 7.5% running gel as
previously described.26 After separation, the gel was blotted
to nitrocellulose and blocked for 1 hour with 2% skimmed
milk. After incubation overnight with the primary antibody,
the secondary antibody was added and allowed to incubate
for 1 hour (Table 1). Then, the blot was incubated with
alkaline phosphatase (AP)–conjugated tertiary antibody
diluted 1:250 for another hour. After washing, the blot was
developed with nitro blue tetrazolium and 5-bromo-4-chloro-
3-indolyl phosphate in AP buffer. All incubation and washing
steps were performed at room temperature. The primary
antibodies rabbit anti-collagen I and VI (Table 1) were
incubated in mouse anti rabbit IgG (Jackson ImmunoRe-
search Laboratories, Inc.) first and then in goat anti-mouse AP
(Bio-Rad); goat anti-collagen IV (Table 1) was incubated in
mouse anti-goat IgG (Jackson ImmunoResearch Laboratories,
Inc.) and then in goat anti-mouse AP (Bio-Rad). The ratio
between the protein of interest and the loading standard
glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Abcam)
was calculated using ImageJ software (http://imagej.nih.gov/
ij/; provided in the public domain by the National Institutes
of Health, Bethesda, MD, USA).
TABLE 1. Antibodies
Primary Antibodies Secondary Antibodies Tertiary Antibodies
Immunohistochemistry for
iERM specimens
Rabbit anti-CRALBP (1:200; from
JC Saari, University of
Washington)
Red-X–conjugated donkey anti-rabbit (1:200;
Jackson ImmunoResearch Laboratories)



















Laboratories)Rabbit anti–type IV collagen (1:100;
Abcam)




Laboratories)Goat anti–type IV collagen
(1:100; SBA)
Western blot Rabbit anti–type I collagen (1:500;
Abcam)




Rabbit anti–type VI collagen (1:500;
Abcam)
Rabbit anti-GFAP (1:500; Abcam)
Goat anti-type IV collagen
(1:500; SBA)
Mouse anti-goat IgG (1:1000; Jackson
ImmunoResearch Laboratories)
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RESULTS
Immunohistochemical Analysis of Flat-Mount
Surgical Samples
General Observations. Positive immunostaining of anti-
GFAP, anti–a-SMA, and anti-CRALBP was found in all tested
samples (Table 2). Among the 15 samples with a positive GFAP
signal, 10 showed a diffuse positivity throughout the entire cell
membrane, whereas 5 contained small clusters of GFAP-
positive cells (Fig. 1).
Colocalization of GFAP/CRALBP and GFAP/a-SMA in
iERM. In iERM samples stained for GFAP/CRALBP, a coex-
pression of GFAP and CRALBP was observed in some of the
cells, whereas other cells were only CRALBP positive (Fig. 2).
These different staining patterns were in adjacent areas. Three
of four iERM specimens stained for GFAP/a-SMA showed a
coexpression of GFAP and a-SMA (Fig. 3).
Presence of Type VI Collagen in iERM. Nine of 10 (90%)
iERM were positive for type VI collagen. In six of the immuno-
positive ERMs, type VI collagen formed a diffuse fine fibrillary
network (Fig. 4). At the edge of the ERM, a direct attachment of
the network to the underlying ILM could be visualized (Fig.
4B).
Immunocytologic Analysis of Cell Cultures
TGF-b1–Induced Effects on MIO-M1 Cells. The TGF-b1
treatment induced significant changes in MIO-M1 cells (Figs.
5E–H) including up-regulation of a-SMA stress fibers and down-
regulation of the intracellular expression of type I, II, and VI
collagens in MIO-M1 cells containing a-SMA–positive stress
fibers.
The quiescent MIO-M1 cells exhibited intracellular positiv-
ity to type I, II, IV, and VI collagens (Figs. 5A–D, green).
Extracellular deposition of type I, II, and VI collagens could be
observed as irregular fibrillar structures. Also, a faint and
diffuse cytoplasmic a-SMA positivity could be observed (Figs.
5A–D, red), but a-SMA stress fibers were rare. After 48 hours of
incubation in 10 ng/mL TGF-b1, a significant up-regulation of a-
SMA stress fibers was observed (Figs. 5E–H, red). Furthermore,
the intracellular expression of type I, II, and VI collagens
appeared to be decreased in MIO-M1 cells containing a-SMA
stress fibers, whereas the cells that did not show a-SMA stress
fibers maintained their intracellular expression of type I, II, and
VI collagens (Figs. 5E–H). The expression of type IV collagen in
a-SMA stress fiber–positive cells appeared to be the least
affected. The staining of type IV collagen in a-SMA stress fiber–
positive cells was less diffusely present than that in the cells
without a-SMA–positive stress fibers and seemed to be more
FIGURE 1. The GFAP-positive cells in idiopathic epiretinal membrane. (A) A surgical sample containing diffuse GFAP positivity (green) throughout
the entire membrane. (B) The GFAP staining of another surgical sample, showing a cluster of GFAP-positive (green) cells. Cell nuclei were stained
blue with DAPI. Scale bars: 200 lm.
FIGURE 2. The expression of GFAP (green) and CRALBP (red) in iERM.
Whole mount of iERM showing some overlap between cells due to
folds in the tissue and due to cells forming no strict monolayer, but
growing on top of each other. Epiretinal cells are sometimes only
CRALBP positive, indicating a Mu¨ller cell origin (arrowheads), whereas
coexpression of GFAP and CRALBP is seen in others, indicating Mu¨ller
cell activation (arrows). Scale bar: 25 lm.
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concentrated around the nucleus. This may be caused by the
fact that these cells are generally more spread, that is, occupy a
larger surface area, than cells without a-SMA stress fibers.
By Western blot analysis, TGF-b1–stimulated Mu¨ller cell
cultures showed an up-regulation of GFAP (3.5-fold increase),
a-SMA (1.5-fold increase), and type VI collagen (27.7-fold
increase) compared with unstimulated Mu¨ller cell cultures
(Fig. 6).
TGF-b1–Induced Effects on Fetal Lung Fibroblasts and
Newborn Skin Fibroblasts. The TGF-b1 treatment induced
up-regulation of a-SMA stress fibers in both fetal lung
fibroblasts and newborn skin fibroblasts. However, the
intracellular staining of type I and VI collagens in both
fibroblast cell lines containing a-SMA stress fibers was similar
to that in the stress fiber–negative cells (Fig. 7).
Specificity of the Antibodies. By light microscopy,
different labeling patterns were found for type I, II, IV, and
VI collagens (Supplementary Fig. S1). Control samples in
which the primary antibody was omitted and samples labeled
with isotype controls (IgG) were negative.
By Western blot analysis, collagen bands could be appreci-
ated at different heights for the different types of collagen,
which is consistent with previous findings by our group,26 and
confirms the specificity of the antibodies (Supplementary Fig.
S2).
DISCUSSION
In this study, we identified type VI collagen as a component of
iERM. Also, we observed cells positive for GFAP and for a-SMA,
which we consider to be transdifferentiated retinal Mu¨ller
cells. In vitro, TGF-b appears to stimulate the retinal Mu¨ller cell
to transdifferentiate into a myofibroblast-like phenotype
expressing a-SMA stress fibers, at the same time decreasing
intracellular collagen expression.
Consistent with previous studies of human Mu¨ller cells,
MIO-M1 cells in response to TGF-b1 obtain an a-SMA stress
fiber–expressing phenotype. Assuming that in vivo Mu¨ller cells
will do the same, these cells will then be able to contract the
ERM on which they are growing, which is corroborated by
FIGURE 3. Images of immunohistochemically stained flat mounted iERMs representing a cluster of epiretinal cells expressing both GFAP (red) and
a-SMA (green). (A) Variability in a-SMA positivity within one sample. Some cells have only weak and patchy a-SMA reactivity (arrow), whereas
others are stained intensely (arrowhead). Scale bar: 100 lm. (B) Colocalization of GFAP (red)– and a-SMA (green)–positive iERM cells. Scale bar: 10
lm.
FIGURE 4. Images of immunohistochemically stained, flat-mounted iERMs stained for type VI collagen (red). (A) Type VI collagen forms a well-
arranged fibrillary network (arrow; scale bar: 100 lm). (B) Focal attachment of a type VI collagen network (ERM) to the underlying ILM (arrows;
scale bar: 50 lm). The whole-mounted iERM-ILM specimen is viewed from the vitreous side, thus showing the iERM on top and the ILM beneath.
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previous data.20 By being incorporated in the stress fibers, a-
SMA is involved in the contractile activity of various cell types,
such as fibroblasts, chondrocytes, and mesenchymal stem
cells.31–33 The de novo expression of a-SMA alone has been
reported to increase the contractile activity of fibroblasts.31
The progression of iERM can be considered as a fibrotic
process because the pathologic findings are an increased
collagen deposition and membrane contraction. Although
some debate exists concerning the initial event of iERM, the
general consent is that the retinal Mu¨ller cell is an important
cell type that plays a central role in this process by producing
various collagens and expressing a-SMA that is involved in the
membrane contraction.16,34–36 Previous publications on freshly
isolated porcine retinal Mu¨ller cells37 and rat retinal Mu¨ller
cells in situ38,39 support the assumption that retinal Mu¨ller
cells can produce collagens. In addition, the observed variable
expression of a-SMA in GFAP-positive glial cells in the
clinicopathologic study indicates that some of the retinal
Mu¨ller cells can produce a-SMA and acquire a contractile
activity. This is consistent with our in vitro results and with
previous in vitro and animal studies that showed that retinal
Mu¨ller cells are actively involved in the formation and
contraction of iERM (Supplementary Fig. S3).16,40–42
Cellular retinaldehyde-binding protein is known to be
expressed in retinal Mu¨ller cells containing 11-cis-retinol and
11-cis-retinaldehyde, whereas the up-regulation of GFAP is a
hallmark of retinal Mu¨ller cell activation.43,44 The simultaneous
expression of CRALBP and GFAP can be used to differentiate
Mu¨ller cells from hyalocytes that have also been shown to be
responsible for the fibrotic tissue formation and expression of
GFAP.45 In our clinicopathologic study, the coexpression of
CRALBP/GFAP and a-SMA/GFAP in ERM samples indicates that
the differentiated CRALBP-positive retinal Mu¨ller cell first
becomes activated (GFAP positivity) and then is being
FIGURE 5. Images of cell cultures of MIO-M1 cells treated with or without TGF-b1 for 48 hours and then fixated and stained with antibodies for a-
SMA and collagens. Immuno–double labeling was performed to colocalize the expression of a-SMA (red) and various collagens (green). In some
photographs, extracellularly deposited collagen can be appreciated (arrows). The nuclei were counterstained with DAPI (blue). (A–D) MIO-M1
cells without TGF-b1. (E–H) MIO-M1 cells treated with TGF-b1 for 48 hours show prominent a-SMA stress fibers and reduced staining for
intracellular type I, II, IV, and VI collagens. (A, E) Type I collagen (green). (B, F) Type II collagen (green). (C, G) Type IV collagen (green). (D, H)
Type VI collagen (green). Scale bars: 10 lm.
FIGURE 6. By Western blot analysis, TGF-b1–stimulated Mu¨ller cell cultures showed an up-regulation of GFAP (3.5-fold increase), a-SMA (1.5-fold
increase), and type VI collagen (27.7-fold increase) compared with unstimulated Mu¨ller cell cultures. The ratio between the protein of interest and
the loading standard GAPDH is depicted in the histogram.
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transformed into a myofibroblast-like cell type (a-SMA positiv-
ity). Thus, the retinal Mu¨ller cell may actively be involved in the
formation of iERM.
Furthermore, we frequently observed cells that only
expressed CRALBP and not GFAP in the vicinity of these
activated Mu¨ller cells. This indicates that the transdifferentia-
tion process is both dynamic and focal. Local factors, yet to be
identified, activate only the cells nearby, which then change
their phenotype, become myofibroblast-like, and start to
contract their matrix. Tissue stiffness is one of the important
local factors that modulate the formation of myofibroblasts by
activating TGF-b. During the formation of iERM, retinal Mu¨ller
cells proliferate and migrate to the vitreal surface of the retina,
which is stiffer than the compliant retinal tissue. Because
previous researches suggest that retinal Mu¨ller cells are
mechanosensitive,46 it is possible that the increase in stiffness
could provide a local environment that facilitates the trans-
differentiation of retinal Mu¨ller cells to a myofibroblast-like
phenotype.
In the current study, we show that the effect of TGF-b on
retinal Mu¨ller cells was not exactly the same as that observed in
fibroblasts. Our study suggests that TGF-b stimulation results in
an overall increase in intracellular GFAP and type VI collagen
and also some up-regulation of a-SMA. In those Mu¨ller cells that
develop a-SMA stress fibers in response to TGF-b1, the
intensity of intracellular staining for type I, II, and VI collagens
seems to decrease. The TGF-b1 treatment did not affect the
intracellular staining of type I and VI collagens in both types of
fibroblasts. These findings indicate that when retinal Mu¨ller
cells express a-SMA stress fibers, their synthesis of type I, II,
and VI collagens is either down-regulated or their secretion of
these collagens into the extracellular matrix is promoted. In
fibroblasts of many organs, TGF-b1 has been well established to
be responsible for excessive deposition of collagens during
fibrotic tissue formation.27,28 Furthermore, TGF-b1 has also
been shown to be involved in the regulation of procollagen
processing and fibrillogenesis, which may result in promoting
the secretion of collagens into the extracellular space. This
suggests that TGF-b1, besides its potent activity to induce
collagen production, can also promote the processing of
procollagens to mature collagens. The possible suppression of
intracellular type I, II, and VI collagen production may indicate
a negative feedback mechanism that regulates the profibro-
genic effect of TGF-b in stress fiber–positive retinal Mu¨ller
cells. High doses of TGF-b have been shown to suppress the
expression of type I collagen via the induction of a negative
regulator of collagen transcription in renal fibroblasts.47
Idiopathic ERMs contain a complex ECM protein network
containing many types of collagens, including type I, II, III, IV,
and VI collagens. Our observations suggest that type VI
collagen forms a fine fibrillar network in iERM, which is
consistent with previous reports.48,49 Kritzenberger et al.7
FIGURE 7. Images of cultures of MIO-M1 cells, fetal lung fibroblasts, and newborn skin fibroblasts treated with TGF-b1 for 48 hours and then fixated
and stained with antibodies for a-SMA and type I and VI collagen. Immuno–double labeling was performed to colocalize the expression of a-SMA
(red) and type I and VI collagen (green). The nuclei were counterstained with DAPI (blue). MIO-M1 cells containing a-SMA stress fibers show
reduced intracellular staining for type I (A) and VI (B) collagens, whereas intracellular collagen staining in fibroblasts containing a-SMA stress fibers
appears to be unaffected (C–F). Scale bars: 10 lm.
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reported the expression of type VI collagen predominantly in
cellophane maculopathy as opposed to preretinal macular
fibrosis. In previous research, type VI collagen expression was
not detected by light microscopy in normal human ILM at the
macular region, nor in ERMs from idiopathic macular hole
patients with the same immunohistochemical technique.29 In
this study, we used commercially available antibodies and
negative and positive controls to reduce the chance of false
interpretations due to antibody cross-reaction. Therefore, we
conclude that the positive staining of type VI collagen is
specific.
The use of a cell culture model has the advantage of offering
a system in which the effects of individual variables such as
TGF-b can be studied. Obvious limitations include the use of an
in vitro system and isolated cells. Thus, findings will only serve
to formulate hypotheses on the in vivo situation, but firm
conclusions cannot be drawn. However, in the present study,
in vitro findings and observations on surgically obtained iERMs
seem to support each other.
In summary, our ex vivo and in vitro studies shed some
new light on the pathogenesis of iERM regarding the
involvement of retinal Mu¨ller cells and the production of
type I, II, and VI collagens in response to TGF-b1. Although
certain debate exists concerning the initial events of iERM
formation, retinal Mu¨ller cells are one of the important cell
types that are actively involved by migration, proliferation,
and transdifferentiation. During the process of iERM forma-
tion, TGF-b can be produced and activated by both retinal
Mu¨ller cells and hyalocytes.50–52 In an autocrine or paracrine
fashion, TGF-b up-regulates the expression of a-SMA in these
epiretinal cells, resulting in the contraction of the epiretinal
membrane. Although the retinal Mu¨ller cells that do not
express a-SMA could continue their production of collagens
to form the ECM network of the iERM, the a-SMA–expressing
retinal Mu¨ller cells are responsible for the membrane
contraction. Whether the reduced intracellular collagen
staining in retinal Mu¨ller cells containing a-SMA stress fibers
is due to reduced production or increased secretion is at
present unresolved.
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